Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Why the big jump in volume?

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Jun 13, 2021 11:15am

145 Views

Post# 33379208

RE:RE:Why the big jump in volume?

Yes please run it back up and buy so I can get out and make some money on this

AngelaL wrote: The shorters are taking their last shot. It will fail. The RS is almost surely going to be approved. Once news comes out, the shorters will be crushed. Now is the time to get in and buy at these absurdly low price levels.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"